Sunday , January 23 2022

Preventing prostate cancer should become normal to follow



[ad_1]

The National Cancer Foundation (INCA) states that, in the year 2018, more than 62,000 new prostate cancer cases will be diagnosed in Brazil, the second most common among men, behind It is a skin cancer that is not melanoma only. The increase in rates comes together with the evolution of diagnostic tests and especially the awareness of men looking for more information about the disease and the ways of preventing the most obvious in campaigns like the Green November.

According to Jonatas Luiz Pereira, a urologist at the Paraná Oncology Institute (IOP), the trend is that new cases have appeared over the years as a result of aging and male population. "We know that age is the main risk factor for prostate cancer. We have a recommendation from the Brazilian Urology Association to start screening for prostate 50-year tumors in men without risk factors, and 45 years in those men with family history of the disease in the father, siblings or uncle. More black population needs to be more focused, as the concept is also a risk factor, "he said. 39; the expert.

During the initial period, the prostate tumor is asymptomatic, that is, it does not have any symptoms. When some signs start to appear, among bone pain and weight loss, about 95% of the tumor is already at a higher stage, which prevents the chances of improving. For this reason, it is essential to keep the usual exams. "We are currently screening for PSA (Prostate Specific Antigen) as well as a rectal examination. If there is any change, we will continue with the investigation." The final diagnosis is carried out by prostate biopsy led by higher geography. of combination, which occurs when we attach unstable and ultrasound images to punch a suspicious inside the prostate. At an early stage, we can talk about improving the disease, but in advanced cases, with metastasis, we focus on the management of the disease, "said the urologist.

The choice for the best treatment will depend on some aspects, such as patient's health status, disease staging and life expectancy. "In the initial cases, the sign may be surgery, radiotherapy, or without or without hormone therapy, and in some situations, active surveillance, which is the way to follow patients with very low risk tumors more closely. The US, for example, the widely available technique, accounts for about 90% of the total number of patients treated with hormone therapy. Every man should be aware of the importance of maintaining practice consult with the urologist, a doctor who regularly evaluates the patient, the curve of PSA results and changes in the prostate examination physically. All types of prevention should normally be followed by, "said Jonatas Luiz Perei ra.

MORE LEARNING

Robotic Surgery: The robotic technique is as efficient as the conventional method. Access in the country is still limited, as only 41 robots operating in Brazil. In Curitiba, there is a robotic surgery by the Erasto Gaertner Hospital.

Immunotherapy: is a treatment that uses the body protection system itself to attack the cancer cells. The main purpose of this therapy is to allow the immune system to act faster to combat the disease. Studies show that 60% of patients will use some form of immunotherapy by 2020. Related treatments include other studies such as chemotherapy with immunotherapy to allow the results.

Genetic tests: BRAC 1 and PRAC 2 genetic tests are mainly aimed at men with breast cancer and / or ovary cases among female and prostate cancer relatives for male relatives seen over several generations. The exam is done after collecting blood or saliva, with the help of the new generation sequencing methodology (NGS). A modern, sensitive assessment that can read all the BRCA1 and BRCA2 gene DNA bases in one test. All the process, from the sample release until the release and report, takes about 20 days.

Hormone treatment: Medicines or surgery are used to regulate the production of androgens (men's hormones) that promote prostate cancer development in patients.

Website: http://iop.com.br

DINO
This includes commercial released by the Dino company and it is not Terra's responsibility

[ad_2]
Source link